Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6755)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2015 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
He AB, Peng XL, Song J, Zhang JX, Dong WG, Luo RF, Tang Y. Efficacy of S-1 |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i14/4358.htm |
| Number | Citing Articles |
| 1 |
Yu Yoshida, Sayaka Sasaoka, Mizuki Tanaka, Kiyoka Matsumoto, Misaki Inoue, Riko Satake, Kazuyo Shimada, Ririka Mukai, Takaaki Suzuki, Mari Iwata, Fumiya Goto, Takayuki Mori, Koki Mori, Tomoaki Yoshimura, Mitsuhiro Nakamura. Analysis of drug-induced hand–foot syndrome using a spontaneous reporting system database. Therapeutic Advances in Drug Safety 2022; 13 doi: 10.1177/20420986221101963
|
| 2 |
S.M.Zeeshan Qadar, Zhiyong Dong, Sheikh Mohammed Shariful Islam, Jianxue Wang, Xiling Xu, Fakhsheena Anjum, Sana Shamim, Bafreen Sherif, Sundas Ali. S-1 plus oxaloplatin (S-1OX) versus capecitabine plus oxaloplatin (CAPOX) for advanced gastric cancer: A systematic review and meta-analysis. Computer Methods and Programs in Biomedicine Update 2024; 5: 100151 doi: 10.1016/j.cmpbup.2024.100151
|
| 3 |
Qingqian Zhang, Yue Qian, Ying Yin. Comparison of S-1-based vs. capecitabine-based adjuvant chemotherapy for patients with gastric cancer: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 2021; 77(12): 1791 doi: 10.1007/s00228-021-03187-w
|
| 4 |
Radka Obermannová, Florian Lordick. Management of Metastatic Gastric Cancer. Hematology/Oncology Clinics of North America 2017; 31(3): 469 doi: 10.1016/j.hoc.2017.01.006
|
| 5 |
Emil ter Veer, Nadia Haj Mohammad, Paul Lodder, Lok Lam Ngai, Mary Samaan, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven. The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis. Gastric Cancer 2016; 19(3): 696 doi: 10.1007/s10120-015-0587-8
|
| 6 |
Jia Chen, Jianping Xiong, Jiejun Wang, Leizhen Zheng, YanFei Gao, Zhongzhen Guan. Capecitabine/cisplatin versus 5‐fluorouracil/cisplatin in Chinese patients with advanced and metastatic gastric cancer: Re‐analysis of efficacy and safety data from the ML17032 phase III clinical trial. Asia-Pacific Journal of Clinical Oncology 2018; 14(5) doi: 10.1111/ajco.12832
|
| 7 |
Yi-Feng Yu, Peng Wu, Rui Zhuo, San-Gang Wu. Metronomic S-1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma. Cancer Research and Treatment 2024; 56(4): 1058 doi: 10.4143/crt.2023.1343
|
| 8 |
D. Klingbiel, B. Thürlimann, P. Brauchli, R. von Moos. Absence of evidence is not evidence of absence: the case of non-inferiority. Annals of Oncology 2017; 28(12): 3100 doi: 10.1093/annonc/mdx498
|
| 9 |
Sayaka Sasaoka, Toshinobu Matsui, Junko Abe, Ryogo Umetsu, Yamato Kato, Natsumi Ueda, Yuuki Hane, Yumi Motooka, Haruna Hatahira, Yasutomi Kinosada, Mitsuhiro Nakamura. Evaluation of the Association of Hand-Foot Syndrome with Anticancer Drugs Using the US Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) Databases. YAKUGAKU ZASSHI 2016; 136(3): 507 doi: 10.1248/yakushi.15-00222
|
| 10 |
Akira Okita, Hiroo Imai, Masahiro Takahashi, Hidekazu Takahashi, Sho Umegaki, Yoshifumi Kawamura, Sakura Hiraide, Kota Ouchi, Yuko Sato, Yoshinari Okada, Keigo Komine, Ken Saijo, Shin Takahashi, Masanobu Takahashi, Hidekazu Shirota, Hisatsugu Ohori, Makio Gamoh, Chikashi Ishioka. Efficacy and Safety of Trastuzumab in Combination with S-1 and Cisplatin Therapy for Japanese Patients with HER2-Positive Advanced Gastric Cancer: Retrospective Analysis. The Tohoku Journal of Experimental Medicine 2018; 245(2): 123 doi: 10.1620/tjem.245.123
|
| 11 |
Anna Koumarianou, Anastasios Ntavatzikos, Christos Vallilas, Katerina Kampoli, Zoi Kakoseou, Michalis V. Karamouzis. Survival Outcomes Following Combination of First-Line Platinum-Based Chemotherapy with S-1 in Patients with Advanced Gastric Cancer. Cancers 2020; 12(12): 3780 doi: 10.3390/cancers12123780
|
| 12 |
Jian-Ye Zhang, Min-Ting Lin, Meng-Jia Zhou, Tao Yi, Yi-Na Tang, Si-Li Tang, Zhi-Jun Yang, Zhong-Zhen Zhao, Hu-Biao Chen. Combinational Treatment of Curcumin and Quercetin against Gastric Cancer MGC-803 Cells in Vitro. Molecules 2015; 20(6): 11524 doi: 10.3390/molecules200611524
|
| 13 |
Hisato Kawakami, Kazuhiro Nishikawa, Toshio Shimokawa, Kazumasa Fujitani, Shigeyuki Tamura, Shunji Endo, Michiya Kobayashi, Junji Kawada, Yukinori Kurokawa, Akira Tsuburaya, Takaki Yoshikawa, Junichi Sakamoto, Taroh Satoh. Histology Classification Highlights Differences in Efficacy of S-1 versus Capecitabine, in Combination with Cisplatin, for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer with Measurable Disease. Cancers 2022; 14(22): 5673 doi: 10.3390/cancers14225673
|
| 14 |
Ryohei Kawabata, Keisho Chin, Daisuke Takahari, Hisashi Hosaka, Osamu Muto, Yoshiaki Shindo, Naoki Nagata, Hiroshi Yabusaki, Hiroshi Imamura, Shunji Endo, Tomomi Kashiwada, Masato Nakamura, Jun Hihara, Michiya Kobayashi, Tamotsu Sagawa, Soh Saito, Atsushi Sato, Takeshi Yamada, Naohiro Okano, Ken Shimada, Masashi Matsushima, Masato Kataoka, Shigemi Matsumoto, Masahiro Goto, Masahito Kotaka, Takeshi Shiraishi, Hiromichi Yamai, Fumio Nagashima, Naoki Ishizuka, Kensei Yamaguchi. Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study. Gastric Cancer 2023; 26(6): 1020 doi: 10.1007/s10120-023-01423-z
|